LeMaitre Vascular, Inc. (LMAT) Misses Q2 EPS by 5c, Cuts FY11 Sales Guidance, Declares Dividend

July 28, 2011 4:28 PM EDT
LeMaitre Vascular, Inc. (NASDAQ: LMAT) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15.05 million.

LeMaitre Vascular, Inc. sees Q3 2011 revenue of $14.6 million, versus the consensus of $14.7 million. Operating income for the quarter is expected to be $1.5 million.

The Company is reducing its full-year 2011 sales guidance by $2.3mm due in large part to its exit from stent grafts. Full-year operating income guidance is after approximately $2.0mm of charges and special items associated with the five strategic initiatives detailed below.

The Company's Board of Directors approved the payment of a quarterly cash dividend on the Company's common stock of $0.02 per share, with payment to be made on September 6, 2011 to shareholders of record at the close of business on August 19, 2011


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Dividends, Earnings, Guidance

Related Entities

Dividend